Assignee
SIRNA THERAPEUTICS INC
US·124 granted patents·182 pending applications·3,384 citations·filing 1999–2025
Top patents by PatentIndex Score
306 records- 0199US10000754B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Jun 19, 2018·35 cites·21 claims
- 0299US9771588B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·44 cites·52 claims
- 0399US9732344B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2016·Granted Aug 15, 2017·43 cites·29 claims
- 0499US9657294B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted May 23, 2017·36 cites·23 claims
- 0599US9181551B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·102 cites·82 claims
- 0698US9604908B2Diether based biodegradable cationic lipids for siRNA deliverySIRNA THERAPEUTICS INC·Filed 2016·Granted Mar 28, 2017·39 cites·6 claims
- 0798US7989612B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Granted Aug 2, 2011·36 cites·10 claims
- 0898US7923547B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Granted Apr 12, 2011·82 cites·3 claims
- 0998US7893302B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2009·Granted Feb 22, 2011·152 cites·1 claims
- 1098US7858769B2RNA interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional siNA)SIRNA THERAPEUTICS INC·Filed 2005·Granted Dec 28, 2010·156 cites·16 claims
- 1198US7491805B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2004·Granted Feb 17, 2009·273 cites·4 claims
- 1298US7404969B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2006·Granted Jul 29, 2008·363 cites·10 claims
- 1398US7109165B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2002·Granted Sep 19, 2006·90 cites·74 claims
- 1498US6673611B2Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionSIRNA THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·218 cites·17 claims
- 1597US7964578B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2008·Granted Jun 21, 2011·66 cites·9 claims
- 1697US7956176B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Granted Jun 7, 2011·42 cites·14 claims
- 1797US7858625B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2005·Granted Dec 28, 2010·22 cites·2 claims
- 1897US7691405B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2008·Granted Apr 6, 2010·51 cites·10 claims
- 1997US7514099B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2006·Granted Apr 7, 2009·67 cites·1 claims
- 2097US6995259B1Method for the chemical synthesis of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2001·Granted Feb 7, 2006·103 cites·16 claims
- 2197US6849726B2Non-nucleotide containing RNASIRNA THERAPEUTICS INC·Filed 2003·Granted Feb 1, 2005·129 cites·12 claims
- 2296US9458090B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2015·Granted Oct 4, 2016·9 cites·17 claims
- 2396US9402816B2Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2013·Granted Aug 2, 2016·10 cites·7 claims
- 2496US6852535B1Polymerase III-based expression of therapeutic RNASSIRNA THERAPEUTICS INC·Filed 2000·Granted Feb 8, 2005·54 cites·13 claims
- 2596US6649751B2Synthesis, deprotection, analysis and purification of RNA and ribozymesSIRNA THERAPEUTICS INC·Filed 2002·Granted Nov 18, 2003·68 cites·184 claims
- 2696US6617438B1Oligoribonucleotides with enzymatic activitySIRNA THERAPEUTICS INC·Filed 1999·Granted Sep 9, 2003·312 cites·27 claims
- 2795US10662428B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2019·Granted May 26, 2020·5 cites·4 claims
- 2895US7795422B2RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2008·Granted Sep 14, 2010·15 cites·5 claims
- 2995US7553830B2Compositions for the delivery of negatively charged moleculesSIRNA THERAPEUTICS INC·Filed 2005·Granted Jun 30, 2009·20 cites·10 claims
- 3095US6818447B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorSIRNA THERAPEUTICS INC·Filed 2000·Granted Nov 16, 2004·49 cites·12 claims
- 3195US6673918B2Deprotection of RNASIRNA THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·65 cites·17 claims
- 3294US9970005B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted May 15, 2018·15 cites·41 claims
- 3394US7777023B2Method for the chemical synthesis of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2005·Granted Aug 17, 2010·23 cites·20 claims
- 3494US6989442B2Deprotection and purification of oligonucleotides and their derivativesSIRNA THERAPEUTICS INC·Filed 2002·Granted Jan 24, 2006·43 cites·24 claims
- 3594US6818759B22′-O-alkylthioalkyl and 2′-C-alkylthioalkyl-containing nucleic acidsSIRNA THERAPEUTICS INC·Filed 2002·Granted Nov 16, 2004·31 cites·1 claims
- 3693US11932854B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2021·Granted Mar 19, 2024·2 cites·25 claims
- 3793US10793860B2RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (SINA)SIRNA THERAPEUTICS INC·Filed 2019·Granted Oct 6, 2020·5 cites·10 claims
- 3893US10351852B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Jul 16, 2019·5 cites·47 claims
- 3993US9879262B2RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2016·Granted Jan 30, 2018·12 cites·15 claims
- 4093US9643916B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2016·Granted May 9, 2017·5 cites·6 claims
- 4193US8835623B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2013·Granted Sep 16, 2014·15 cites·20 claims
- 4293US7641915B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2008·Granted Jan 5, 2010·19 cites·1 claims
- 4392US9464290B2RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted Oct 11, 2016·11 cites·15 claims
- 4492US7517864B2RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2005·Granted Apr 14, 2009·16 cites·16 claims
- 4592US7205399B1Methods and reagents for oligonucleotide synthesisSIRNA THERAPEUTICS INC·Filed 2002·Granted Apr 17, 2007·67 cites·20 claims
- 4692US7041817B2Synthesis, deprotection, analysis and purification of RNA and ribozymesSIRNA THERAPEUTICS INC·Filed 2002·Granted May 9, 2006·24 cites·12 claims
- 4791US11193126B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2018·Granted Dec 7, 2021·7 cites·40 claims
- 4891US10689648B2Short interfering nucleic acid (siNA) compositionsSIRNA THERAPEUTICS INC·Filed 2017·Granted Jun 23, 2020·5 cites·19 claims
- 4990US10407682B2RNA interference mediated inhibition of hepatitis B Virus (HBV) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·7 cites·10 claims
- 5090US9062021B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2014·Granted Jun 23, 2015·6 cites·6 claims
Showing the top 50 of 306 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →